Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Gastroenterology

How Do I Read My CSID Disaccharidase Biopsy Results?

At a Glance

A CSID biopsy report measures digestive enzyme activity in a small-intestinal sample. Low sucrase, sometimes with low isomaltase and normal lactase, may support CSID, but it does not confirm an inherited diagnosis without considering lab ranges, tissue health, symptoms, and follow-up testing.

When you receive your disaccharidase (digestive enzyme) assay biopsy results, you are looking at a measurement of how well the enzymes in your small intestine break down complex sugars into absorbable nutrients. These reports often contain complex metrics, but doctors look closely at the pattern of these numbers.

A pattern of low sucrase and low isomaltase activity combined with normal lactase activity often supports or raises suspicion for Congenital Sucrase-Isomaltase Deficiency (CSID) [1]. However, this pattern does not automatically confirm a genetic diagnosis. Your doctor will interpret these numbers alongside your symptoms and the physical health of your tissue samples [2].

What This Test Can and Cannot Tell You

  • It measures sampled activity: It shows enzyme activity in the specific tiny pieces of tissue removed during your endoscopy, not necessarily your entire intestine [3].
  • It does not prove genetics: Low numbers show a deficiency, but they do not automatically prove the deficiency is primary (inherited genetically).
  • Handling matters: Results can be heavily influenced by how quickly the tissue was frozen and handled at the lab [4].
  • Symptoms vary: A low enzyme value alone does not guarantee that carbohydrate maldigestion is the only cause of your symptoms [5].

What Does “U/g Protein” Mean?

You will likely see your enzyme activity measured in U/g protein (Units per gram of protein) [6][7].

Because the tiny tissue samples taken during an endoscopy vary in size, the lab normalizes the enzyme activity against the amount of protein in the sample. This ensures the measurement reflects enzyme activity rather than just the size of the biopsy piece [7]. While this helps standardize the measurement, it does not eliminate the risk of errors from poor specimen handling or from the specific location where the biopsy was taken [4].

Check Your Lab’s Reference Range First

Different laboratories use different assay methods and populations to determine their cutoffs. Always compare your numbers to the reference limits printed on your specific lab report.

For context, large clinical studies have often used the following numbers as example lower limits of normal [6]:

  • Sucrase: 25 U/g protein
  • Maltase: 100 U/g protein
  • Lactase: 10 to 15 U/g protein
  • Palatinase: 5 to 9 U/g protein

Understanding the Terminology:

  • Palatinase: Laboratories often use palatinase as a surrogate (substitute) measure to estimate your isomaltase activity, though it isn’t a direct, pure measurement of all isomaltase function [8].
  • Maltase-glucoamylase: Another enzyme complex that helps digest starches. Because it overlaps with sucrase-isomaltase, maltase numbers can be tricky to interpret [8].

What Your Number Patterns Might Mean

The pattern of your results provides clues about what is happening in your gut.

  • Low Sucrase with Normal Lactase: This pattern raises clinical suspicion for primary CSID [1]. It suggests the specific mechanism that creates sucrase is impaired, while the rest of the intestine is healthy enough to produce lactase. However, it requires clinical context to confirm.
  • Variable Palatinase (Isomaltase): While sucrase is generally low in CSID, your isomaltase (palatinase) activity can range from completely absent to nearly normal [9].
  • Maltase Complexity: Maltase activity is influenced by both the sucrase-isomaltase and maltase-glucoamylase enzymes [8]. Your doctor will evaluate maltase in the context of your overall enzyme pattern.
  • Low Across the Board: If all your enzymes (including lactase) are low, it might point to secondary damage—meaning another condition temporarily damaged your intestine. Conditions like celiac disease or inflammation can cause villous blunting (flattening of the intestinal absorptive surface) and reduce all enzyme production [10]. Alternatively, an all-low result could simply mean the tissue sample was inadequate or degraded before reaching the lab [4].

Understanding Enzyme Ratios

Some laboratory reports include ratios, such as a sucrase-to-lactase ratio. While these ratios can help your doctor spot descriptive patterns, there is no universally validated ratio threshold for diagnosing CSID [11]. Therefore, absolute activity values and the physical health of the tissue sample carry more weight than ratios alone.

Next Steps and Additional Testing

Because a biopsy only provides a snapshot of your tissue, your doctor may recommend additional testing to build a complete diagnosis [12]:

  • Genetic Testing: A blood or saliva test can look for genetic mutations that cause CSID. However, tests may not detect every clinically relevant variant, and having a variant doesn’t guarantee you will have severe symptoms [13].
  • Sucrose Breath Testing: A non-invasive test measuring how well you digest sucrose. Keep in mind that breath tests can be affected by other factors like bacterial overgrowth (SIBO) or how fast food moves through your gut [4].

Do not make extreme, long-term changes to your diet—like cutting out all carbohydrates—based solely on a lab report without guidance from a doctor or registered dietitian.

Common questions in this guide

What enzyme pattern can suggest CSID on a biopsy report?
Low sucrase activity, especially when lactase is normal and isomaltase or palatinase is also low, can raise suspicion for CSID. This pattern is not a diagnosis by itself; your clinician also considers your symptoms, the health of the sampled tissue, and the laboratory’s reference ranges.
What does U/g protein mean on a disaccharidase test?
U/g protein means enzyme activity is reported in units per gram of protein in the biopsy sample. This adjustment helps account for differences in sample size, but it does not remove the effects of biopsy location or poor tissue handling and freezing.
Can a low disaccharidase result prove that I have inherited CSID?
No. Low activity can also occur when the intestinal lining is affected by celiac disease, inflammation, or another temporary injury, and a sample can be inadequate or degraded. Genetic testing may help, but it does not detect every relevant change and a genetic variant does not predict symptom severity on its own.
What does it mean if all of my enzyme levels are low?
Low levels across all enzymes may suggest damage to the intestinal lining, such as flattening associated with celiac disease or inflammation. It can also reflect a small or poorly preserved sample, so the pathology findings and specimen handling should be reviewed.
Should I use a sucrase-to-lactase ratio to diagnose CSID?
Ratios can describe a pattern, but no single ratio cutoff has been universally validated to diagnose CSID. The absolute enzyme values, your laboratory’s printed reference ranges, symptoms, and tissue findings usually matter more.
What tests can clarify a possible CSID diagnosis?
A blood or saliva genetic test can look for changes linked to CSID, while a sucrose breath test measures how your body handles sucrose without another biopsy. Breath results can be affected by bacterial overgrowth or how quickly food moves through the gut, and genetic tests may miss some relevant changes.
Should I stop eating all carbohydrates after a low biopsy result?
No; a low enzyme result alone does not show that all carbohydrates must be removed or that carbohydrate maldigestion is the only cause of symptoms. Discuss targeted diet changes with your clinician or a registered dietitian, especially before making long-term restrictions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do these enzyme values suggest primary CSID, or could secondary mucosal damage (like inflammation) be playing a role?
  2. 2.Did the pathology report show any villous blunting (flattening of the intestinal lining), celiac disease, or inflammation in my biopsy samples?
  3. 3.How do you interpret my specific enzyme ratios in the context of my overall lab report?
  4. 4.Given that biopsy results can sometimes be affected by sample handling, would a sucrose breath test or genetic testing be helpful to clarify my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Clinical Characteristics of Disaccharidase Deficiencies Among Children Undergoing Upper Endoscopy.

    Cohen SA, Oloyede H, Gold BD, et al.

    Journal of pediatric gastroenterology and nutrition 2018; (66 Suppl 3()):S56-S60 doi:10.1097/MPG.0000000000001961.

    PMID: 29762380
  2. 2

    Demystifying Carbohydrate Maldigestion: A Clinical Review.

    Cash BD, Patel D, Scarlata K

    The American journal of gastroenterology 2025; (120(4S)):1-11 doi:10.14309/ajg.0000000000003374.

    PMID: 40249016
  3. 3

    Diagnosing sucrase-isomaltase deficiency: a comparison of a 13C-sucrose breath test and a duodenal enzyme assay.

    Dale HF, Hagen M, Deb C, et al.

    Scandinavian journal of clinical and laboratory investigation 2024; (84(4)):268-272 doi:10.1080/00365513.2024.2377960.

    PMID: 38984772
  4. 4

    Diagnosing Congenital Sucrase-Isomaltase Deficiency in Children: An Algorithm Using Combined Breath Testing.

    Hoskins BJ, Freeman J, Kutty S, et al.

    Pediatric gastroenterology, hepatology & nutrition 2026; (29(2)):120-130 doi:10.5223/pghn.2026.29.2.120.

    PMID: 41877710
  5. 5

    Disaccharidase deficiencies and gastrointestinal symptoms in patients referred to gastroscopic examination: a single center study from Norway.

    Dale HF, Hagen M, Bekkelund M, et al.

    Scandinavian journal of gastroenterology 2024; (59(10)):1166-1171 doi:10.1080/00365521.2024.2395848.

    PMID: 39230142
  6. 6

    Reference Intervals for Intestinal Disaccharidase Activities Determined from a Non-Reference Population.

    Hackenmueller SA, Grenache DG

    The journal of applied laboratory medicine 2016; (1(2)):172-180 doi:10.1373/jalm.2016.020388.

    PMID: 33626784
  7. 7

    Effects of Nutrient Restriction During Midgestation to Late Gestation on Maternal and Fetal Postruminal Carbohydrase Activities in Sheep.

    Trotta RJ, Vasquez-Hidalgo MA, Vonnahme KA, Swanson KC

    Journal of animal science 2020; (98(1)) doi:10.1093/jas/skz393.

    PMID: 31879771
  8. 8

    Metabolic Impacts of Maltase Deficiencies.

    Nichols BL, Baker SS, Quezada-Calvillo R

    Journal of pediatric gastroenterology and nutrition 2018; (66 Suppl 3()):S24-S29 doi:10.1097/MPG.0000000000001955.

    PMID: 29762372
  9. 9

    The patient journey to diagnosis and treatment of congenital sucrase-isomaltase deficiency.

    Smith H, Romero B, Flood E, Boney A

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2021; (30(8)):2329-2338 doi:10.1007/s11136-021-02819-z.

    PMID: 33772704
  10. 10

    Clinical and Histopathologic Predictors of Disaccharidase Deficiency in Duodenal Biopsy Specimens.

    Reed RC, Pacheco MC

    American journal of clinical pathology 2019; (152(6)):742-746 doi:10.1093/ajcp/aqz091.

    PMID: 31332425
  11. 11

    A retrospective study on the association of gastrointestinal symptoms in children with low lactase activity and low activity of other disaccharidases.

    Wasuwanich P, Choudry H, Ingviya T, et al.

    BMC gastroenterology 2020; (20(1)):331 doi:10.1186/s12876-020-01443-4.

    PMID: 33036568
  12. 12

    Genetic and acquired sucrase-isomaltase deficiency: A clinical review.

    Danialifar TF, Chumpitazi BP, Mehta DI, Di Lorenzo C

    Journal of pediatric gastroenterology and nutrition 2024; (78(4)):774-782 doi:10.1002/jpn3.12151.

    PMID: 38327254
  13. 13

    A call for caution in expanding the mutational spectrum of SI gene deficiency.

    Spurná Z, Fišer M, Macek M, Schwarz M

    Scandinavian journal of gastroenterology 2026; (61(9)):916-921 doi:10.1080/00365521.2026.2681103.

    PMID: 42223142

This page is for informational purposes only and does not constitute medical advice. Your gastroenterologist and care team should interpret your biopsy results and recommend any diet changes.

Get notified when new evidence is published on Congenital sucrase-isomaltase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.